# Fate Therapeutics Inc: Form SCHEDULE 13D/A, filed Apr 22, 2026

- Company: [Fate Therapeutics Inc](/companies/fate.md) (CIK 1434316)
- Form: SCHEDULE 13D/A
- Filed: 2026-04-22
- Accepted by EDGAR: Apr 22, 2026, 21:47 ET
- Period: not reported
- Accession: 0001104659-26-047066
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1434316/000110465926047066/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1434316/000110465926047066/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1434316/000110465926047066/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Apr 22, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-047066. Last ingested by Listed: Nov 5, 2026, 19:31 ET. No prices; not investment advice.